3Biotech’s Post

As a biotech, it can be difficult to raise the capital needed to perform your first clinical trial. But without a trial, you don’t have the data to submit to the FDA. Running a trial requires you to cashflow your firm for 12-24 months - and that’s just to see the study through. On top of all that, you’re also accountable to your shareholders.. Oh, and you’re competing with large biotech firms who have (seemingly) unlimited funding. So, what options do you have? In this longform article we deep dive into the challenges US biotechs are facing and some potential solutions we suggest. Link below! #clinicalresearch #preclinical #clinicaltrials #biotechnology

🔬 Unlocking the Future of Laboratory Safety: The Biological Safety Cabinet Market is Evolving 🌍 In today's world, laboratory safety is more crucial than ever. Our latest report on the #biologicalsafetycabinet Market delves into the dynamics shaping this essential industry. From the rising emphasis on biosafety standards to technological advancements in cabinet design, the market is witnessing significant growth. The report provides in-depth insights into key trends, #competitivelandscapes, and future forecasts that will guide stakeholders in making informed decisions. 📊 Key Highlights: ▪ Surge in demand across #pharmaceutical and biotechnology sectors ▪ Technological innovations driving enhanced safety and efficiency ▪ Regulatory frameworks influencing market dynamics Whether you're a manufacturer, supplier, or industry professional, this report offers the insights you need to stay ahead in this evolving market. 📥 Download the full report now to stay informed and make data-driven decisions. https://lnkd.in/e5tpE__K #MarketInsights #Biosafety #LabSafety #Biotechnology #ResearchAndDevelopment

Bruce Booth & Atlas Venture are out with their annual year-in-review for #biotech & #pharma. As usual, it's full of interesting stuff, but I was really struck by this slide that shows the hill biopharma companies are climbing. Over the past decade, the average cost to develop a therapy is up by $1 billion. At the same time, success rates have fallen, as has the average value of an approved drug. The science right now is incredibly exciting. Crossed fingers that the other variables required for success -- regulatory frameworks, IP protection, interest rates, etc. -- incentivize break through treatments in 2025 and beyond. The whole presentation is worth your time. https://lnkd.in/eEzQEwDK Recommended, Biorasi!

Unravel the future of life science outsourcing with our 2024 sector and marketing trend report 🧬 Our comprehensive report offers insights from industry experts to help you navigate the challenges and seize the opportunities ahead. Download your copy now 👉 https://loom.ly/dMOfMPA #LifeScienceTrends #Outsourcing #Pharma #Biotech #Innovation

We're a biopharma engineering company, a small but essential piece of the massive life sciences ecosystem. By bringing together our customers, partners, industry thought leaders, regulators and governments, we affect a greater impact and bring our mission to life. #Biopharma #LifeSciences #HealthcareInnovation #Biotechnology #Engineering #Collaboration #FutureOfHealthcare #ImpactfulInnovation #GlobalHealth #IndustryLeaders #Regulators #GovernmentPartnerships #MissionDriven #ScienceForGood

Discover the surprising journey from thousands of compounds to just a handful where science meets possibility in the search for new medicines. Ever wonder how new medicines are found? Well, it's quite a journey! Imagine starting with around 10,000 different chemical compounds. After lots of testing in labs and on animals, only about 250 of them show real potential. And guess what? Just 10 of those get to be tested on people! It's like finding a needle in a haystack, but when it happens, it's a big deal. Stay tuned for the next pharma facts Comment with your thoughts below. #drugdiscovery #fascinatingfacts #pharma

📣 Big Savings Alert! 📣 If you've considered enrolling in our next #marketaccess training course, now is the time! We have a limited number of seats remaining, and we want the class to be full. Enroll today using the discount code "FINALSEATS" to save 50% (That's $2,250 in savings). Learn more about the curriculum and enroll here: https://lnkd.in/gnhHMGBN October 22 & 23, 20204 in Philadelphia, PA #pharma #biotech #elevateandaccelerate #traininganddevelopment

Biotechnology innovations hold immense promise, but navigating the complex regulatory landscape is critical for success. Recognizing the unique challenges faced by biotech companies—from early-stage research to commercialization—is vital. A thorough understanding of regulatory requirements, paired with strategic planning, can help mitigate risks and streamline the path to market. As the biotech industry evolves, staying informed and adapting compliance strategies will be key to accelerating patient access to groundbreaking therapies! #regulatoryaffairs #usfda #biotech

The ArisGlobal Breakthrough event promises to be an excellent opportunity for interaction with Regulatory peers. We hope you can join us and your colleagues to discover the innovative methods we're employing to enhance the success of Regulatory teams. #regulatoryaffairs #regulatoryoperations

The Pistoia Alliance recently conducted a survey as a pulse check on which laboratory technologies the #pharma / #biotech industry is investing in and companies' progress integrating new tech into their labs. Check out the key findings in this new article by Becky Upton: https://lnkd.in/euazW9XV #drugdevelopment #advancedtechnologies